Par : Liu Peng
Date : jeudi 21 janvier 2027
12:00 - 13:00
Immunogenic cell death (ICD) promotes antitumor immunity by releasing danger signals that are sensed by dendritic cells (DCs), thereby linking cancer cell death to adaptive immune responses. Formyl peptide receptor 1 (FPR1) is a pattern-recognition receptor expressed by DCs and plays a critical role in the recognition of dying tumor cells and the initiation of effective anticancer immunity. Importantly, functional genetic variants of FPR1 are relatively frequent in the human population and have been associated with impaired responses to anticancer therapy, as well as increased cancer susceptibility and earlier disease onset. This talk focuses on how FPR1 variants affect DC functions and contribute to defective antitumor immune responses. By combining genetic and functional approaches, we characterize variant-specific alterations in DC sensing and explore strategies to overcome these defects, providing a basis for personalized strategies to restore impaired antitumor immunity.
Tous les séminaires